In a 20-page comment submitted to the FDA on May 14, 2012, the Pharmaceutical Research and Manufacturers of America (PhRMA), advised the FDA to "proceed cautiously and in a manner that fully protects the free speech rights of advertisers and patients" with regard to the agency's recent Draft Guidance for Industry on Direct-to-Consumer (DTC) Television Advertisements."Recall that the Food and Drug Administration Amendments Act of 2007 (FDAAA) gives FDA the authority to ".
PhRMA -- the US pharmaceutical trade association -- just now published an oblique critique of the FDA for fiddling with issuing its promised social media guidelines while pharma Facebook pages burn in response to new commenting poli... Read Post
PhRMA is itching to challenge FDA's authority to regulate DTC advertising in front of the Supreme Court, arguing that recent "Draft FDA Guidance on PreDissemination Review of TV Direct-to-Consumer Ads" (find it here) violates the Fr... Read Post
According to a press release issued today, the Pharmaceutical Research and Manufacturers of America (PhRMA) Board of Directors has adopted measures to strengthen the PhRMA Guiding Principles on Direct to Consumer Advertisements abou... Read Post